SQSTM1 and melanoma: Both p62 and AMBRA1 expression exemplify how autophagy can be harnessed as prognostic biomarkers for melanoma, each providing clinically relevant information over and above AJCC staging, which in particular will be useful for refining the risk of melanoma progression in patients with AJCC stage I or II melanomas.